Cramer's 7 Stocks in 60 Seconds: BIIB DHI TOL CSCO PCLN HUN MLNX (Update 1)

Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".


(Updates from 10:45 a.m. ET with closing information.)

NEW YORK ( TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk On The Street" Thursday:

Cramer noted how strong Biogen Idec ( BIIB) stock is even though the company's ALS drug failed. "I think this is a great company," Cramer said. BIIB shares closed down 1.4% Thursday.

Surprised at Stifel Nicolaus upgrading both DR Horton ( DHI) and Toll Brothers ( TOL), Cramer said, "It's a bit late," then added, "This is the impetus behind the group going up." DHI and TOL both closed flat.

Cramer thinks the Cisco ( CSCO) upgrade to outperform by RBC is important. "Cisco is doing better than people think," he said. CSCO closed up 1%.

Following another upgrade on Priceline.com ( PCLN), Cramer called it "the last darling standing." PCLN was up 1.6%.

Speaking about Huntsman ( HUN), Cramer said its new CEO could stabilize and take the stock to $20 a share. HUN ended the day up 3.3%.

By contrast, calling it the disaster du jour, Cramer pointed to the stock falloff at Mellanox Technologies ( MLNX) after the CFO left. "Ask Herb Greenberg," he said of his CNBC colleague. "That's all you need to know." MLNX plummeted 17% Thursday.

To sign up for Jim Cramer's free Booyah! newsletter, with all of his latest articles and videos, please click here.

-- Written by Anthony Buccino in New York.
At the time of publication, Cramer's Action Alerts PLUS had no position in the stocks mentioned.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on TheStreet.com. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

If you liked this article you might like

Illumina Lights the Way for Biotechs

Illumina Lights the Way for Biotechs

European Pharma Companies Slip on MS Pricing Probe

Biogen Stock Climbs After Goldman Adds to its 'Conviction Buy' List

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire